Sector
PharmaceuticalsOpen
₹138Prev. Close
₹140.92Turnover(Lac.)
₹445.12Day's High
₹140.4Day's Low
₹136.0752 Week's High
₹155.552 Week's Low
₹86.4Book Value
₹42.45Face Value
₹2Mkt Cap (₹ Cr.)
3,502.71P/E
0EPS
0.26Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|
Equity Capital | 49.89 | 58.81 | 49.67 | 49.67 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 1,008.48 | 982.28 | 979.84 | 836.54 |
Net Worth | 1,058.37 | 1,041.09 | 1,029.51 | 886.21 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Revenue | 265.45 | 227.33 | 106 | 90.71 |
yoy growth (%) | 16.77 | 114.45 | 16.85 | -77.01 |
Raw materials | -108.86 | -113.04 | -79.37 | -72.52 |
As % of sales | 41.01 | 49.72 | 74.87 | 79.94 |
Employee costs | -22.41 | -17.09 | -11.85 | -17.9 |
Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Profit before tax | 43.44 | 22.81 | 1.82 | -15.16 |
Depreciation | -9.12 | -8.95 | -3.66 | -3.25 |
Tax paid | -8.77 | -1.47 | -2.86 | 0 |
Working capital | 33.97 | -80.01 | -110.8 | 56.46 |
Other operating items |
Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 16.77 | 114.45 | 16.85 | -77.01 |
Op profit growth | 58.69 | -220.94 | -39.83 | -186.01 |
EBIT growth | 65.64 | 1,156.67 | -115.03 | -154.81 |
Net profit growth | 50.47 | -94.74 | -33,86,825 | -100.11 |
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 1,369.73 | 1,420.91 | 1,412.82 | 1,361.62 | 1,179.24 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 1,369.73 | 1,420.91 | 1,412.82 | 1,361.62 | 1,179.24 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 10.96 | 6.39 | 10.85 | 8.36 | 10.09 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,568.65 | 123.31 | 3,76,323.69 | 867.6 | 0.86 | 5,536.99 | 98.75 |
Divis Laboratories Ltd DIVISLAB | 4,519.8 | 76.17 | 1,19,994.45 | 531 | 0.66 | 2,259 | 507.93 |
Cipla Ltd CIPLA | 1,485.5 | 32.29 | 1,19,928.54 | 1,038.4 | 0.57 | 3,444.92 | 346.41 |
Zydus Lifesciences Ltd ZYDUSLIFE | 1,144.45 | 33.51 | 1,15,173.54 | 1,405.2 | 0.26 | 3,172.6 | 156.19 |
Dr Reddys Laboratories Ltd DRREDDY | 6,636 | 25.85 | 1,10,759.07 | 1,034.8 | 0.6 | 5,081.8 | 1,458.96 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non-Exec. & Independent Dir.
Kausalya Santhanam
Joint Managing Director
Sharat Narasapur
Company Sec. & Compli. Officer
Krunal Shah
Non-Exec & Non-Independent Dir
Neeraj Bharadwaj
Non-Exec & Non-Independent Dir
Gregory John Andrews
Non-Exec & Non-Independent Dir
Fabian Kausche
Chairman & Independent Directo
Kamal K Sharma
Non-Exec. & Independent Dir.
Milind Sarwate
Managing Director & CEO
N Rajaram
Director
Hari Babu Bodepudi
Company Sec. & Compli. Officer
PHILLIP TROTT
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Sequent Scientific Ltd
Summary
Visistha Traders & Finance Ltd, has amalgamated PI Drugs & Pharmaceuticals Ltd with itself. The High court has sanctioned the Scheme of Amalgamation and the same was filed with ROC by the company on Nov 12, 2003.
Read More
The Sequent Scientific Ltd shares price on N/A is Rs.₹142.35 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Sequent Scientific Ltd is ₹3551.36 Cr. as of 22 Jul ‘24
The PE and PB ratios of Sequent Scientific Ltd is 0 and 3.24 as of 22 Jul ‘24
The 52-week high/low is the highest and lowest price at which a Sequent Scientific Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Sequent Scientific Ltd is ₹86.03 and ₹155.45 as of 22 Jul ‘24
Sequent Scientific Ltd's CAGR for 5 Years at 16.07%, 3 Years at -23.32%, 1 Year at 57.18%, 6 Month at 2.73%, 3 Month at 18.28% and 1 Month at 16.38%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.